Frank Morich, Director at Cue Biopharma, Inc. (CUE), bought 28,000 shares at $3.75 ($105K) on 2022-05-27, disclosed to the SEC on 2022-05-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.